Navigation Links
Stemedica Achieves Major Milestone - Company Receives License to Manufacture Clinical Grade Stem Cells
Date:9/1/2009

Stemedica Cell Technologies, Inc., ("Stemedica"), a leader in adult stem cell research and manufacturing, announced today that it has been granted a license by the State of California's Food & Drug Branch to manufacture stem cells for human clinical trials. This Drug Manufacturing License recognizes Stemedica as being compliant with California law and the applicable provisions of the Code of Federal Regulations.

San Diego, CA (PRWEB) Sep 1, 2009 -- Stemedica Cell Technologies, Inc., ("Stemedica"), a leader in adult stem cell research and manufacturing, announced today that it has been granted a license by the State of California's Food & Drug Branch to manufacture stem cells for human clinical trials. This Drug Manufacturing License recognizes Stemedica as being compliant with California law and the applicable provisions of the Code of Federal Regulations.

"This is an important development for Stemedica." said Nikolai Tankovich, MD, PhD, President and Chief Medical Officer of Stemedica. "With this license we become an even stronger worldwide leader within the stem cell industry. Our stem cells and stem cell-derived factors can now be purchased by pharmaceutical and biotech companies, research institutions and medical facilities conducting approved human clinical trials. As more and more organizations get involved with stem cell research and clinical trials, including drug discovery programs, Stemedica's ability to service their needs becomes a critical asset to the organization and to the industry."

"This stamp of approval positions Stemedica as one of only a few companies in the world capable of manufacturing and delivering its own unique multiple cell products and factors. The Company also has the ability to
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related biology technology :

1. Stemedica Selected By World Stem Cell Summit To Present Scientific Discoveries
2. Stemedica Requests Pre-IND Meeting With FDA
3. Stemedica Signs Scientific Advisory Board Agreement with Leading Pediatric Burn & Wound Care Researcher
4. Renowned Stem Cell Researcher Files Study Results With Stemedica
5. CIRM Completes Briefing Visit to Stemedica Cell Technologies
6. Stemedica Announces the Appointment of Dr. Michael Bayer as Director, Medical Services
7. BioNeutrals Ygiene(TM) Hospital Grade Achieves a 100% Total Kill (Pass) Against the Life Threatening Clostridium Difficile (C.diff) Spores in Independent EPA Required Protocol Testing.
8. BioNeutrals Ygiene(TM) Hospital Grade Achieves World Class Independent Test Results in Killing Life Threatening Spores/Organisms
9. Environmental Tectonics Corporations BioMedical Division Achieves Foreign Manufacturer Accreditation in Japan
10. Healthy Advice Networks Achieves Strong Growth Despite Challenging Economy
11. Pepscan Achieves a Breakthrough With CLIPS Immunogen Technology: Synthetic Peptide Antigen is Able to Induce Fully Functional Antibodies Against a Formerly Intractable GPCR Target CXCR7
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Stemedica Achieves Major Milestone - Company Receives License to Manufacture Clinical Grade Stem Cells 
(Date:8/20/2014)... 2014 GraphDB™ 6.0 ... improvements to the enterprise replication cluster, faster loading ... SOLR and Elasticsearch. This release happens to coincide ... triplestore – GraphDB™ was formerly known as OWLIM. ... only mature enterprise resilient RDF triplestore will also ...
(Date:8/19/2014)... 2014 A Geisinger researcher on a personal ... Centers for Disease Control and Prevention (CDC) award recognizing ... concern. Joseph Boscarino , Ph.D. MPH, ... team of researchers nominated for the Centers for Disease ... for Data Methods and Study Design. "Hepatitis ...
(Date:8/19/2014)... 2014 XenoTech announces an exclusive ... metabolite production from bioactive small molecules. Based ... technology enables convenient and timely assessment of critical ... Vice President of Commercial Operations, Christian Darabant, “the ... risk can be measured directly by comparison with ...
(Date:8/19/2014)... Md. , Aug. 19, 2014   ... biotechnology company developing novel anti-infective biologic and drug ... and diseases, announced today that its novel ... at the 54 th Interscience Conference on ... Washington D.C. ...
Breaking Biology Technology:Ontotext Improves Its RDF Triplestore, GraphDB™ 6.0: Enterprise Resilience, Faster Loading Speeds and Connectors to Full-Text Search Engines Top the List of Enhancements 2Ontotext Improves Its RDF Triplestore, GraphDB™ 6.0: Enterprise Resilience, Faster Loading Speeds and Connectors to Full-Text Search Engines Top the List of Enhancements 3Ontotext Improves Its RDF Triplestore, GraphDB™ 6.0: Enterprise Resilience, Faster Loading Speeds and Connectors to Full-Text Search Engines Top the List of Enhancements 4Geisinger investigator nominated for federal award 2Geisinger investigator nominated for federal award 3Beyond Metabolite Identification, Testable Quantities Now Offered by XenoTech 2Beyond Metabolite Identification, Testable Quantities Now Offered by XenoTech 3Synthetic Biologics Announces Late-Breaking Poster Presentation for C. difficile Program at 54th ICAAC 2Synthetic Biologics Announces Late-Breaking Poster Presentation for C. difficile Program at 54th ICAAC 3Synthetic Biologics Announces Late-Breaking Poster Presentation for C. difficile Program at 54th ICAAC 4
... National Stem,Cell Holding, Inc. (OTC: NHGI.PK) today ... a newly discovered group of,biomaterials, derived from the ... stimulate a variety of naturally occurring physiological,mechanisms that ... and repair,itself . These newly discovered biomaterials ...
... 15 /PRNewswire-FirstCall/ - Helix BioPharma Corp.,(TSX: HBP / Frankfurt: ... as Chairman and a director of the Company to ... involvement with the Company since its,amalgamation in 1995," said ... the Company, I thank him for his positive,contributions and ...
... 15 Senex Biotechnology, Inc. presented,today new results ... International,Conference on Alzheimer,s Disease Drug Discovery in New ... the identification of the first,drug candidates that block ... involved in Alzheimer,s disease, including: amyloid,precursor protein (APP); ...
Cached Biology Technology:National Stem Cell Holding Announces Patent Application for Newly Discovered Cellular Derived Biomaterials for Anti-Aging Applications 2National Stem Cell Holding Announces Patent Application for Newly Discovered Cellular Derived Biomaterials for Anti-Aging Applications 3Helix BioPharma Chairman resigns 2Senex Biotechnology Announces Presentation of Alzheimer's Disease Drug Discovery Effort 2Senex Biotechnology Announces Presentation of Alzheimer's Disease Drug Discovery Effort 3
(Date:8/20/2014)... The National Institutes of Health has awarded the Oklahoma ... continue its research on anthrax and the bacteria,s effects ... Mark Coggeshall, Ph.D., and his colleagues have studied the ... NIH,s Cooperative Centers for Human Immunology. The original funding ... 17 on the heels of the terrorist attacks of ...
(Date:8/20/2014)... burning spiciness that is irresistible to some, but intolerable ... using their findings to develop a new drug candidate ... by inflammation or other problems. They reported their progress ... trials, in ACS, Journal of Medicinal Chemistry . ... scientists had pegged a compound called capsaicin as the ...
(Date:8/20/2014)... Mo. A new gene therapy developed by researchers ... been shown to protect mice from a life-threatening heart ... a new therapeutic avenue," said Yi Lai, Ph.D., the ... in the MU School of Medicine,s Department of Molecular ... but we hope this could lead to a treatment ...
Breaking Biology News(10 mins):$14.5 million grant awarded to continue anthrax studies 2Gene therapy protects mice from lethal heart condition, MU researchers find 2
... DCDecember 17, 2008The 2009 American Society for Microbiology ... be presented to Jo Handelsman, Ph.D., Professor and ... This award recognizes an educator for outstanding teaching ... has taught over 1,100 undergraduates and even more ...
... Fellowship in the American Academy of Microbiology. Fellows ... highly selective, peer-review process, based on their records ... advanced microbiology. There are now over 2,000 Fellows ... applied research, teaching, public health, industry, and government ...
... A collaboration research carried out by the teams ... Carlos Izpisa-Belmonte and ngel Raya, Centre for Regenerative Medicine ... Energetic, Environmental and Technological Research (CIEMAT), has resulted in ... patients with a genetic disease known as Fanconi anemia. ...
Cached Biology News:Seventy-three scientists elected to the American Academy of Microbiology 2Seventy-three scientists elected to the American Academy of Microbiology 3Seventy-three scientists elected to the American Academy of Microbiology 4Genetically corrected blood cells obtained from skin cells from Fanconi anemia patients 2
... Labeling Kit generates labeled cDNA for use ... is made via a reverse transcription from ... Unlike other methods, there are no unnatural ... reaction. This unmodified cDNA is then labeled ...
... An easy-to-use solution that enables fully automated ... 400 Hybridization Station has been designed to ... the throughput necessary to perform a wide ... performed in the range 485C; denaturations of ...
... user-friendly Eppendorf Thermomixer R offers maximum ... require shaking, heating, and cooling. Its ... its application and temperature control ranges. ... accommodate 24 micro test tubes, are ...
... is a high quality microarray scanner based on ... rejection and spatial resolution. The DNAscope LM ... cost microarray scanner that is upgradeable to a ... Features: Includes control module (computer), ...
Biology Products: